Abstract:ABSTRACT Bacteria and their viral predators (phages) are constantly evolving to subvert one another. Many bacterial immune systems that inhibit phages are encoded on mobile genetic elements that can be horizontally transmitted to diverse bacteria. Despite the pervasive appearance of immune systems in bacteria, it is not often known if these immune systems function against phages that the host encounters in nature. Additionally, there are limited examples demonstrating how these phages counter-adapt to such immune systems. Here, we identify clinical isolates of the global pathogen Vibrio cholerae harboring a novel genetic element encoding the bacterial immune system DarTG and reveal the immune system’s impact on the co-circulating lytic phage ICP1. We show that DarTG inhibits ICP1 genome replication, thus preventing ICP1 plaquing. We further characterize the conflict between DarTG-mediated defense and ICP1 by identifying an ICP1-encoded protein that counters DarTG and allows ICP1 progeny production. Finally, we identify this protein, AdfB, as a functional antitoxin that abrogates the toxin DarT likely through direct interactions. Following the detection of the DarTG system in clinical V. cholerae isolates, we observed a rise in ICP1 isolates with the functional antitoxin. These data highlight the use of surveillance of V. cholerae and its lytic phages to understand the co-evolutionary arms race between bacteria and their phages in nature. IMPORTANCE The global bacterial pathogen Vibrio cholerae causes an estimated 1 to 4 million cases of cholera each year. Thus, studying the factors that influence its persistence as a pathogen is of great importance. One such influence is the lytic phage ICP1, as once infected by ICP1, V. cholerae is destroyed. To date, we have observed that the phage ICP1 shapes V. cholerae evolution through the flux of anti-phage bacterial immune systems. Here, we probe clinical V. cholerae isolates for novel anti-phage immune systems that can inhibit ICP1 and discover the toxin-antitoxin system DarTG as a potent inhibitor. Our results underscore the importance of V. cholerae and ICP1 surveillance to elaborate novel means by which V. cholerae can persist in both the human host and aquatic reservoir in the face of ICP1.

Phage defence by deaminase-mediated depletion of deoxynucleotides in bacteria.

Activation of a Vibrio cholerae CBASS anti-phage system by quorum sensing and folate depletion

A Vibrio cholerae Anti-Phage System Depletes Nicotinamide Adenine Dinucleotide to Restrict Virulent Bacteriophages

The Vibrio cholerae Seventh Pandemic Islands act in tandem to defend against a circulating phage

Sporadic phage defense in epidemic Vibrio cholerae mediated by the toxin-antitoxin system DarTG is countered by a phage-encoded antitoxin mimic

Diverse phage defence systems define West African South American pandemic Vibrio cholerae

A Vibrio cholerae Type IV restriction system targets glucosylated 5-hydroxymethylcytosine to protect against phage infection

SspABCD–SspE is a Phosphorothioation-Sensing Bacterial Defence System with Broad Anti-Phage Activities

A widespread phage-encoded kinase enables evasion of multiple host antiphage defence systems

Molecular mechanism of plasmid elimination by the DdmDE defense system

DNA glycosylases provide antiviral defence in prokaryotes

Vibrio cholerae pathogenicity island 2 encodes two distinct types of restriction systems

The antiphage defense system CBASS controls resistance and enables killing by antifolate antibiotics in Vibrio cholerae

A highly specific phage defense system is a conserved feature of the Vibrio cholerae mobilome

Systematic Discovery of Phage Genes that Inactivate Bacterial Immune Systems

A functional selection reveals previously undetected anti-phage defence systems in the E. coli pangenome

Anti-viral defence by an mRNA ADP-ribosyltransferase that blocks translation

A Type IV restriction system targets glucosylated 5-hydroxyl methyl cytosine to protect against phage infection

The Vibrio cholerae CBASS phage defence system modulates resistance and killing by antifolate antibiotics

Anti-viral defense by an ADP-ribosyltransferase that targets mRNA to block translation